Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025)

Tyra Biosciences (TYRA) has 6 years of Accumulated Depreciation data on file, last reported at $1.4 million in Q1 2025.

• Quarterly Accumulated Depreciation rose 50.43% year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.4 million (up 50.43% YoY) and the FY2024 annual result came in at $1.3 million, up 58.74% from the prior year.
• Accumulated Depreciation advanced to $1.4 million in Q1 2025, from $1.3 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $1.4 million in Q1 2025 to a low of $119000.0 in Q3 2021.
• A 5-year average of $678466.7 and a median of $629000.0 in 2023 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2021 — Accumulated Depreciation soared 293.02% — and 2025, when it jumped 50.43%.
• Tracing TYRA's Accumulated Depreciation over 5 years: stood at $169000.0 in 2021, then surged by 172.78% to $461000.0 in 2022, then jumped by 75.05% to $807000.0 in 2023, then soared by 58.74% to $1.3 million in 2024, then increased by 8.74% to $1.4 million in 2025.
• The last three Accumulated Depreciation figures came in at $1.4 million (Q1 2025), $1.3 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.